
Organigram Global fell 48.0% from $1.64 to $0.85, behind the S&P 500's +9.8%. Its worst day was May 12 (−15.3%), and its low came Nov 10 at $0.85.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.20 missed the $-0.01 estimate on $58.2M revenue (est. $53.1M).
+8.9% · S&P 500 −0.3%
EPS of $0.10 beat the $-0.01 estimate on $45.6M revenue (est. $53.5M).
Story events cover the past 12 months · Times ET
−12.6% · S&P 500 −0.3%
Organigram Global shares rose 10.4%, while the S&P 500 rose 1.0%.
+10.4% · S&P 500 +1.0%
EPS of $-0.01 beat the $-0.01 estimate on $43.6M revenue (est. $52.1M); FY revenue guidance of $255.2M against the $341.4M consensus.
−15.3%, the year's worst day · S&P 500 −0.2%
EPS of $0.56 beat the $-0.01 estimate on $76.4M revenue (est. $67.7M); FY revenue guidance of $255.2M against the $241.4M consensus.
+17.1%, the year's best day, on 24M shares, the year's heaviest volume · S&P 500 −0.3%
Where it ended: a close of $0.85 on Nov 10, 2026. Up next: Q4 2026 earnings on Dec 15, 2026 (EPS est. $0.02, revenue est. $85.4M).
Nothing in the past 12 months.
All OGI analyst actionsNothing in the past 12 months.
All OGI dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for OGI and SPY from Benzinga historical bars. Not investment advice.